These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15070605)

  • 41. The effect of subareolar isosulfan blue injection on pulse oximeter readings.
    Zengel B; Yararbas U; Bingolballi O; Denecli AG
    Indian J Surg; 2014 Feb; 76(1):76-80. PubMed ID: 24799789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free.
    Wasserberg N; Tulchinsky H; Schachter J; Feinmesser M; Gutman H
    Eur J Surg Oncol; 2004 Oct; 30(8):851-6. PubMed ID: 15336731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anaphylaxis to isosulfan blue.
    Laurie SA; Khan DA; Gruchalla RS; Peters G
    Ann Allergy Asthma Immunol; 2002 Jan; 88(1):64-6. PubMed ID: 11814281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [False low oximetry reading caused by patent blue vital dye during breast surgery].
    Nasif LA; Campos JM; Piñol S; Delgado MO; Casas JI; Landeira JM
    Rev Esp Anestesiol Reanim; 2005 Mar; 52(3):169-71. PubMed ID: 15850305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oximetry and patent blue five dye.
    McEwan D; Lam K
    Anaesth Intensive Care; 1997 Oct; 25(5):587-8. PubMed ID: 9352783
    [No Abstract]   [Full Text] [Related]  

  • 46. Pulse oximetry and patent blue vital dye.
    Lee BB
    Acta Anaesthesiol Scand; 2003 Apr; 47(4):491; author reply 491. PubMed ID: 12694153
    [No Abstract]   [Full Text] [Related]  

  • 47. Localization of nonpalpable breast lesions using hook-wire combined with isosulfan blue dye.
    Zografos GC; Doumitriou C; Lappas D; Karatzikos G; Bami E; Fotiadis C; Menenakos E; Androulakis G
    J Surg Oncol; 2003 Jan; 82(1):73-4. PubMed ID: 12501171
    [No Abstract]   [Full Text] [Related]  

  • 48. Interference of patent blue dye with pulse oximetry readings, methemoglobin measurements, and blue urine in sentinel lymph node mapping: a case report and review of the literature.
    Lai HC; Hsu HM; Cherng CH; Lin SL; Wu CT; Yu JC; Yeh CC
    Acta Anaesthesiol Taiwan; 2011 Dec; 49(4):162-4. PubMed ID: 22221691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isosulfan blue affects pulse oximetry.
    Vokach-Brodsky L; Jeffrey SS; Lemmens HJ; Brock-Utne JG
    Anesthesiology; 2000 Oct; 93(4):1002-3. PubMed ID: 11020754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in pulse oximetry after patent blue dye injection into the uterine cervix.
    Vieira SC; Sousa RB; Tavares MB; de Abreu BA; Ibiapina JO; de Sousa Oliveira AK; Zeferino LC
    Ann Surg Oncol; 2008 Oct; 15(10):2862-6. PubMed ID: 18696155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [False decrease in pulse oximetry readings due to patent blue in a patient with breast cancer].
    Murakami T; Kayo R; Kajita I; Cho S; Saito H
    Masui; 2003 Aug; 52(8):909-11. PubMed ID: 13677292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sentinel node mapping affects intraoperative pulse oximetric recordings during breast cancer surgery.
    Koivusalo AM; Von Smitten K; Lindgren L
    Acta Anaesthesiol Scand; 2002 Apr; 46(4):411-4. PubMed ID: 11952442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. More about isosulfan blue.
    Ziser A
    Isr Med Assoc J; 2002 Dec; 4(12):1169. PubMed ID: 12516922
    [No Abstract]   [Full Text] [Related]  

  • 54. Prolonged skin staining after intradermal use of patent blue in sentinel lymph node biopsy for breast cancer.
    Govaert GA; Oostenbroek RJ; Plaisier PW
    Eur J Surg Oncol; 2005 May; 31(4):373-5. PubMed ID: 15837042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intradermal blue dye to identify sentinel lymph node in breast cancer.
    Giuliano AE
    Lancet; 1997 Sep; 350(9082):958. PubMed ID: 9314891
    [No Abstract]   [Full Text] [Related]  

  • 56. Adverse skin lesions after methylene blue injections for sentinel lymph node localization.
    Stradling B; Aranha G; Gabram S
    Am J Surg; 2002 Oct; 184(4):350-2. PubMed ID: 12383900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anaphylaxis and other adverse reactions to blue dyes: a case series.
    Howard JD; Moo V; Sivalingam P
    Anaesth Intensive Care; 2011 Mar; 39(2):287-92. PubMed ID: 21485680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unexplained decrease in measured oxygen saturation by pulse oximetry following injection of Lymphazurin 1% (isosulfan blue) during a lymphatic mapping procedure.
    Coleman RL; Whitten CW; O'Boyle J; Sidhu B
    J Surg Oncol; 1999 Feb; 70(2):126-9. PubMed ID: 10084657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prolonged interference of patent blue on pulse oximetry readings.
    Chia YY; Liu K; Kao PF; Sun GC; Wang KY
    Acta Anaesthesiol Sin; 2001 Mar; 39(1):27-32. PubMed ID: 11407292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Severe decrease in SpO
    Yüksel E; Duman D; Yeniay L; Ulukaya S
    Turk J Surg; 2018; 34(1):74-76. PubMed ID: 29756115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.